BG102541A - Diagnostics and mediators of inflammatory processes - Google Patents

Diagnostics and mediators of inflammatory processes

Info

Publication number
BG102541A
BG102541A BG102541A BG10254198A BG102541A BG 102541 A BG102541 A BG 102541A BG 102541 A BG102541 A BG 102541A BG 10254198 A BG10254198 A BG 10254198A BG 102541 A BG102541 A BG 102541A
Authority
BG
Bulgaria
Prior art keywords
mediators
diagnostics
inflammatory processes
treatedagainst
tomonoclonal
Prior art date
Application number
BG102541A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sampath Parthasarathy
Russel MEDFORD
Original Assignee
Emory University
Atherogenics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University, Atherogenics Inc. filed Critical Emory University
Publication of BG102541A publication Critical patent/BG102541A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
BG102541A 1996-09-20 1998-06-15 Diagnostics and mediators of inflammatory processes BG102541A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2640196P 1996-09-20 1996-09-20
US3933397P 1997-03-17 1997-03-17
PCT/US1997/016695 WO1998012561A1 (en) 1996-09-20 1997-09-19 Diagnostics for and mediators of inflammatory disorders

Publications (1)

Publication Number Publication Date
BG102541A true BG102541A (en) 1999-02-26

Family

ID=26701197

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102541A BG102541A (en) 1996-09-20 1998-06-15 Diagnostics and mediators of inflammatory processes

Country Status (16)

Country Link
US (1) US20020052000A1 (xx)
EP (1) EP0883811A1 (xx)
JP (1) JP2000500879A (xx)
KR (1) KR19990071477A (xx)
AU (1) AU722625B2 (xx)
BG (1) BG102541A (xx)
BR (1) BR9710402A (xx)
CA (1) CA2237191A1 (xx)
CZ (1) CZ146598A3 (xx)
EA (1) EA002520B1 (xx)
HU (1) HUP0102907A1 (xx)
NO (1) NO982265L (xx)
NZ (1) NZ330475A (xx)
PL (1) PL326750A1 (xx)
SK (1) SK66198A3 (xx)
WO (1) WO1998012561A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225070B1 (en) 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
CA2348685A1 (en) * 1998-11-06 2000-05-18 Emory University Biomarkers for oxidative stress
US6953666B1 (en) 1998-11-06 2005-10-11 Emory University Biomarkers for oxidative stress
JP4629175B2 (ja) * 1999-12-16 2011-02-09 日油株式会社 モノクローナル抗体
US6495335B2 (en) 2000-12-07 2002-12-17 Mario Chojkier Compositions and methods for diagnosing alzheimer's disease
US20040126767A1 (en) * 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US20040121350A1 (en) * 2002-12-24 2004-06-24 Biosite Incorporated System and method for identifying a panel of indicators
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP1613946A4 (en) * 2003-03-20 2006-07-12 Univ Northeastern Ohio INCLUDED TEST DEVICE FOR FAST DETECTION OF BIOLOGICAL CONTAMINANTS
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
MX2007000208A (es) * 2004-07-01 2007-08-07 Schepens Eye Res Inst Composiciones y metodos para tratar trastornos y condiciones del ojo.
US8129123B2 (en) 2004-10-05 2012-03-06 The Regents Of The University Of California Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
KR101230740B1 (ko) * 2010-09-08 2013-02-07 인제대학교 산학협력단 자간전증의 조기 진단 및 예후 평가 방법
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
PL3311158T3 (pl) 2015-06-19 2023-11-27 Sera Prognostics, Inc. Pary biomarkerów do przewidywania przedwczesnego porodu
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675281A (en) * 1984-07-09 1987-06-23 Lands William E M Quantification of hydroperoxides using prostaglandin H synthase
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
DE69423436T2 (de) * 1993-06-25 2000-09-07 Smithkline Beecham P.L.C., Brentford An lipoprotein gebundene phospholipase a2, inhibitoren davon und deren verwendung für diagnose und therapie
AU1117397A (en) * 1995-10-27 1997-05-15 Board Of Regents Of The University Of Nebraska, The Novel acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease

Also Published As

Publication number Publication date
NZ330475A (en) 1999-11-29
AU4647397A (en) 1998-04-14
SK66198A3 (en) 1999-09-10
EA199800460A1 (ru) 1998-12-24
KR19990071477A (ko) 1999-09-27
CA2237191A1 (en) 1998-03-26
WO1998012561A1 (en) 1998-03-26
HUP0102907A1 (hu) 2004-05-28
BR9710402A (pt) 1999-08-17
PL326750A1 (en) 1998-10-26
JP2000500879A (ja) 2000-01-25
NO982265D0 (no) 1998-05-18
CZ146598A3 (cs) 1998-11-11
NO982265L (no) 1998-07-16
AU722625B2 (en) 2000-08-10
EP0883811A1 (en) 1998-12-16
EA002520B1 (ru) 2002-06-27
US20020052000A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
BG102541A (en) Diagnostics and mediators of inflammatory processes
ZA874759B (en) Peptide composition and method for the detection of antibodies to htlv-iii
DE60041818D1 (de) Gereinigtes antigen für die alzheimer krankheit und verfahren zu dessen herstellung und verwendung
EP1361229A3 (en) Use of Tyrosine Kinase (PYK2) to produce antibodies
ATE153701T1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
NO973444L (no) Fremgangsmåter og forbindelser for magnetrelaksometrisk påvisning av analytter, samt anvendelse av slike
DE69115267D1 (de) Antigen-/antiantigenspaltung.
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
DE3587268D1 (de) Verfahren zur isolierung des mycobakteriellen antigens-a60 und die verwendung dieses antigens zur herstellung von immunologischen reagenzien und in immunologischen testverfahren.
ATE115729T1 (de) Testverfahren und reagenziensatz dafür.
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
AU525403B2 (en) Purified antigen
ATE398137T1 (de) Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
GB2260609B (en) Separation and analysis
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
FI922666A0 (fi) Diagnostiskt foerfarande.
EP0364971A3 (en) Process for the detection of legionella antigens in body fluids and the like, as well as a test kit for performing the process
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
EP0316764A3 (en) Detection of tumor-associated markers in biological fluids
MD1656F1 (en) Method of diagnosis of the autoimmunity processes in chronical hepatitis
SU682790A1 (ru) Пробоотборник пульпы из пульпопровода
MY104917A (en) Monoclonal antibodies and methods for diagnosis of phytophora infection
SE8704114D0 (sv) Monoclonal antibody, a process for its preparation and the use thereof
EP0207979A4 (en) IMMUNOLOGICAL METHOD FOR MEASURING UNSTABLE ANALYTES USING CROSS-REACTIVE ANTIBODIES.